Log in to save to my catalogue

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e77ffb40639493498684eb7479943fa

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury

About this item

Full title

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury

Publisher

Switzerland: MDPI AG

Journal title

Marine drugs, 2014-12, Vol.13 (1), p.29-47

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Neonatal hypoxic-ischemic encephalopathy causes neurodegeneration and brain injury, leading to sensorimotor dysfunction. Xyloketal B is a novel marine compound isolated from a mangrove fungus Xylaria species (no. 2508) with unique antioxidant effects. In this study, we investigated the effects and mechanism of xyloketal B on oxygen-glucose deprivat...

Alternative Titles

Full title

Marine compound xyloketal B reduces neonatal hypoxic-ischemic brain injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2e77ffb40639493498684eb7479943fa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2e77ffb40639493498684eb7479943fa

Other Identifiers

ISSN

1660-3397

E-ISSN

1660-3397

DOI

10.3390/md13010029

How to access this item